Johnson & Johnson’s quiet pivot: drug price cuts and tariff relief signal a new era

Johnson & Johnson’s recent agreement with the Trump administration marks a key moment in U.S. drug pricing reform. By joining the TrumpRx platform and offering Medicaid pricing aligned with wealthy nations, the company gains tariff relief while promising significant price reductions. This deal signals a potential turning point in the complex balance between pharmaceutical profits, government policy, and patient access.

Read More

Florida Becomes First State to Kill All Vaccine Mandates – A Move That Could Change America Forever

Florida just detonated a political bombshell. In a move that will rattle Big Pharma, enrage public health officials, and electrify millions of parents, Florida Surgeon General Joseph Ladapo has announced that the state plans to end all vaccine mandates—including those required for children to attend school. At a press conference alongside Governor Ron DeSantis, Ladapo…

Read More

Dead Weight: Is the U.S. Government Prepping a Nuclear Culling to Power Its AI Future?

In an age where artificial intelligence is king and energy is the crown jewel, whispers are turning into warnings: the U.S. government may be laying the groundwork for the unthinkable — a large-scale nuclear “event” on home soil. The reason? Freeing up power for the coming AI takeover. And no, this isn’t satire. With China…

Read More

Trump Strikes Back: The End of Billions to Gates’ Vaccine Empire

A silent war has been raging beneath the surface, a battle not fought with weapons, but with control. For decades, shadowy figures have pulled the strings, siphoning taxpayer money into the veins of globalist institutions masquerading as humanitarian efforts. Now, the tide is turning. President Donald J. Trump has done what many feared—and what even…

Read More